Close Menu
Surgical Times
    X (Twitter) Instagram TikTok
    Surgical Times
    • The Pulse
    • Under the Knife
    • Daily Chart
    • Cutting Edge
    • Doc Talk
    Thursday • May 29, 2025
    Surgical Times
    Home»News Releases

    Breast implants: Report of squamous cell carcinoma and various lymphomas in scar tissue around breast implants

    By Press ReleaseSeptember 20, 2022

    On 8 September 2022, the US Food and Drug Administration (FDA) issued a safety communication informing patients and providers about reports of squamous cell carcinoma and various lymphomas located in the capsule or scar tissue around breast implants. The risk of squamous cell carcinoma and other lymphomas occurring in the tissue around breast implants appears to be extremely rare.

    These emerging reports of cancers in scar tissue and capsule are different from Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). More information on BIA-ALCL can be found on the TGA Breast Implant Hub.

    At this time, there is not enough information to say whether breast implants cause these cancers or if some implants pose higher risk than others. For this reason, instances of squamous cell carcinoma, lymphoma and any cancer located in the scar tissue or capsule around breast implants should be reported to the TGA.

    Symptoms of these conditions can include swelling, pain, lumps, or skin changes. However, it is important to note that these symptoms can also reflect other breast health issues.

    Women with breast implants should continue to routinely monitor their breast implants- external site and consult their implanting surgeon if they have any concerns. At this time, medical experts do not recommend breast implant removal in patients without symptoms or other abnormality.

    The TGA is monitoring the occurrence of the disease in Australia and is in communication with other international regulators and experts in Australia.

    The TGA strongly encourages you to report all problems associated with medical devices, including breast implants. Your reports help us monitor the performance and safety of medical devices.

    Visit the ‘Report a problem or side effect‘ webpage to complete the online form and share any problems you may be experiencing. Please include as much information as you can, including implant/explant dates, model, and serial numbers.


    Australian Government, Department of Health and Aged Care, Therapeutic Goods Administration

    Published: 20 September 2022

    BIA-SCC Cancer
    Top News

    America’s Best Plastic Surgeons Announced

    Superior Court Strikes SLAPP Suit Brought by Surgery Center

    Breast Implant Statistics

    30 Months Removed, Woman’s Breast Implants Are Full of Mold

    Top Exclusives

    Death Prompts Public Dig Into Surgeon’s Past: Jessica Jones’s ‘Justice for Hillary’

    Infrared Saunas a ‘Catalyst’ for ‘Breast Implant Illness’ Healthcare CEO Says

    FDA Analysis: Top 10 Symptoms of BII, Reported Rate of Improvement Post Explant

    Surgeon Counters Claims he Botched Woman’s Nose, Deletes Bad Reviews

    Objective. Independent. Informative. Public interest reporting on the practice of plastic surgery not affiliated with or funded by any surgeon, device manufacturer, or practice.

    Instagram X (Twitter) TikTok Facebook YouTube Pinterest
    • Terms
    • Contact
    • Privacy

    © 2025 Surgical Times. All Rights Reserved.

    • Best Of
    • Brazilian Butt Lift Surgery
    • Breast Implants
    • Breast Implant Illness
    • Celebrities
    • Death
    • Ethics
    • Exclusive
    • Florida
    • Uplifting
    • Legal
    • Marketing
    • Mold
    • Money
    • Podcasts
    • Safety
    • Social
    • Statistics
    • Studies
    • Türkiye
    • U.S.
    • U.S. FDA
    • World
    • Press Releases

    Type above and press Enter to search. Press Esc to cancel.